Janet Pope Janetbirdope
5 years 3 months ago
Does she or doesn’t she have swollen jts during telemed call? Referred pts with suspected IA marked swollen jts on a mannequin. In 1637 pts 3/4 marked 1 or more jts ~41% had SJC by Rheum exam. Sens 87% but spec only 31%. Reasonable screen. POS1418 @RheumNow @eular_org #EULAR2021
Janet Pope Janetbirdope
5 years 3 months ago
What costs more in #SLE? Hospitalization for lupus nephritis or for mental health? @RheumNow @eular_org #EULAR2021 POS0304
Janet Pope Janetbirdope
5 years 3 months ago
Can I use #Rituximab during #pandemic? Ritux blunts response to #SARSCoV2 #vaccine LB0003 & worse outcomes vs other Rheum meds (also pred) from Global Rheum Alliance OP0006 but pts on Rituximab have worse disease ~ANCA vasculitis& diff to Rx RA. @RheumNow @eular_org #EULAR2021
Janet Pope Janetbirdope
5 years 3 months ago
Pts will achieve LESS remission in RA, PsA & SpA if high pain catastrophizing score ~50% less remission in RA, even less in PsA (but not stat signif in PsA) ~75% less in axSpA. OP0089 @RheumNow @eular_org #EULAR2021
Janet Pope Janetbirdope
5 years 3 months ago
Rx of lupus nephritis in 2022 should have LESS prednisone, MMF + one of #voclosporin or #belimumab or #obinutizumab or #tacrolimus etc. Combine #MMF with another immunesuppressant for better outcomes #EULAR2021 @RheumNow @eular_org Voclosporin sustained benefit at 2 yrs POS0681
Janet Pope Janetbirdope
5 years 3 months ago
tyk2 makes sense to inhibit in PsA. Part of kinase family including JAK/TYK2, TYK2 is ⬆️in PsA. Deficiency of TYK2 gives less autoimmune diseases. @RheumNow @eular_org #EULAR2021 BMS Tyk Talk symposium https://t.co/knP9n0Qc0u
Robert B Chao, MD doctorRBC
5 years 3 months ago
@KDAO2011 animal support is crucial to #EULAR2021 learning! https://t.co/Y1OalGcU6c
Paul Studenic Stiddyo
5 years 3 months ago
@ARD_BMJ @alessia_alunno Retrospective picture from Friday evening replacing and in honour of the #EULAR2021 congress dinner. https://t.co/jzPp1s2SZD
Md Yuzaiful Md Yusof Yuz6Yusof
5 years 3 months ago
Our Final poll results from #EULAR2021 are out. Landslide victory for #ANA to not be routinely monitored in patients treated with #TNF inhibitors or only checked when features of SLE are present @RheumNow https://t.co/4AGxHGPkco
Janet Pope Janetbirdope
5 years 3 months ago
?Counter intuitive to have ⬇️autoimmune conditions in Sero+ RA vs seronegative but could be due to other genes that are more common in seronegative ex TNF promoter gene, PTPN22 CARD15, STAT4 etc that cluster with IBD, DMType1 etc & not shared epitope POS0313 #EULAR2021 @RheumNow https://t.co/eqLCTIU7A7
David Liew drdavidliew
5 years 3 months ago
You get more general autoimmune disease in seropos RA, right?
Not compared to seroneg RA, as it so happens (incidence and point prevalence).
If anything, it leans the other way - what number of things is seroneg RA, anyway?
DANBIO data POS0313 #EULAR2021 @RheumNow https://t.co/mKJQ2jjCU4
Dr. John Cush RheumNow
5 years 3 months ago
Video: Psoriatic Arthritis Highlights from #EULAR2021 Dr. Jack Cush
https://t.co/xedmiZKOd5 https://t.co/AShEze5rFy
Dr. John Cush RheumNow
5 years 3 months ago
Find our #EULAR2021 psoriatic arthritis coverage in one place.
https://t.co/NzB2e2Vfwb https://t.co/P8TfUxfA3F
Dr. John Cush RheumNow
5 years 3 months ago
Dr. Jack Cush reviews highlight presentations from Virtual #EULAR2021.
https://t.co/yjId7QNRRR
Dr. John Cush RheumNow
5 years 3 months ago
Novel TYK2 Inhibitor Efficacious for Treatment of Psoriatic Arthritis by Dr. Meral K El Ramahi (@MeralElRamahiMD ) #EULAR2021
https://t.co/l6YnJvuPdi

